Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yossi Gross | M | 77 |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | 16 years |
Amir Dagan | M | - |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | 16 years |
Ilan Neugarten | M | 70 |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | - |
Guy Ezekiel | M | 54 |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | 11 years |
David Mark Steinhaus | M | - |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | - |
Susan Lin | F | - |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | - |
Erez Adunsky | M | - |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | 3 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jiawen Shen
- Personal Network